This study is the first to report the detection of the 3.4 kb mitochondrial DNA deletion in plasma and establish and validate a useful diagnostic threshold for the accurate detection of CS prostate cancer for men in the PSA ‘grey zone’. This evidence concerns the gene KLK3 and Familial prostate cancer.